i tendered. For many reasons.
medgen and bupa wellness tendered. 2 of my biggest competitors.
I collect most of the stats they ask for anyway.
The clinical care pathways i found are what we do anyway.
My average session rate and fees are competitive.
Physiotherapy in central london is now more competitive; i believe that for the first time, supply outstrips demand. My experience is that the 'big boys' don't play by the rules of mutual respect and professionalism. Frankly I would rather deal with BUPA than expect solidarity from some physio businesses. I would not be at all surprised if some of those who made the greatest noise tendered in order to clean up.
Before this tender process a successful business model for private practice could be one which charged the most, for the maximum amount of sessions you can give. The patient doesn't care when it is covered by BUPA, so the competitiveness of the marketplace is skewed and the normal market dynamics have not taken place. Now, finally, recognition for practices based at least partly on efficiency will take place. If there are specialisations your stats should be able to demonstrate this; thus valid reasons for significantly higher sessional averages. If there is no specialisation, we will all ahve to change our business models to attract a greater volume of new referrals.
I don't believe my clinical autonomy is at risk. I can back up my assertions with lots of statistics, which include outcome measures (however reliable they are). Most of what BUPA ask are what we do to keep up our standards anyway. When I saw more complex cases, I was able to back up my stats and I was still recognised without having to give a discount.
But...I did not offer a reduction on fees. IMO that would be the beginning of the end. This is where theMRI went sour: they all offered reductions based on the expectation that they would get an increase of volume. But everyone tendered! so no increase of volume.
BUPA are more than 50% of my business. The cost/benefit analysis for me has been simple.